Cvijic Christine Mikail
Transaction: 07/07/2026
SELL
Change
-4,200
Price
$36.13
Filing
07/07/2026
Type
SELL
Neurogene Inc.
NGNE • Biotechnology
$25.45
▲ +0.05 (+0.20%)
Current price
EarningsLatest report: Jun 30, 2026
HIGHER-RISK PROFILECautionConfidence: 70%
Quantitative profile — not an investment recommendation.
Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Caution is warranted. Recent ratios show weaknesses that may limit returns unless fundamentals improve.
Market Cap
$573.95M
Growth
—
Cash Flow
0/5
Trend
Negative
Evidence
Manageable debt level · 0.04Healthy liquidity · 16.56Weak profitability
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Aug 13, 2026, 12:11 PM UTC
Company Snapshot
Key valuation, quality, financial strength, momentum and analyst data.
Price$25.45
Change0.20%
Shares Out22.55M
Market Cap$573.95M
Enterprise Value$356.90M
52W Range15.93 - 43.66
Beta1.95
P/E-5.17
P/B2.64
P/FCF-6.59
EV/EBITDA-3.07
EV/FCF-4.10
Price$25.45
Change0.20%
Shares Out22.55M
Market Cap$573.95M
Enterprise Value$356.90M
52W Range15.93 - 43.66
Beta1.95
P/E-5.17
P/B2.64
P/FCF-6.59
EV/EBITDA-3.07
EV/FCF-4.10
Earnings Yield-19.36%
FCF Yield-15.18%
Dividend Yield0.00%
Gross Margin0.00%
Oper. Margin0.00%
Profit Margin0.00%
Debt/Eq0.04
Current Ratio16.56
Quick Ratio16.56
Target$72.00
Target Upside182.91%
Target Median$70.00
Target Range65.00 - 81.00
Volume342.64K
Avg Volume194.29K
EPS Surprise-0.09
Investment DNA
How strong this company looks for long-term investors
47
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
76/100
Growth Potential
Revenue and expansion
50/100
Price Attractiveness
Cheap or expensive today
90/100
Why this score▼
Manageable debt level · 0.04Healthy liquidity · 16.56Weak profitability
Analyst view
Analyst sentiment and price target
Analyst sentiment
Based on 7 analyst votes · 2026-10-20
93/100
Bullish
Bullish
6
Hold
1
Bearish
0
Price Target
2026-08-13
Low
$65.00
Mean
$72.00
Median
$70.00
High
$81.00
Insider Transactions
Recent executive and insider activity
Cvijic Christine Mikail
Transaction: 07/06/2026
SELL
Change
-600
Price
$36.02
Filing
07/07/2026
Type
SELL
Cvijic Christine Mikail
Transaction: 07/02/2026
SELL
Change
-1,530
Price
$35.23
Filing
07/02/2026
Type
SELL
| Insider | Type | Change | Price | Transaction | Filing |
|---|---|---|---|---|---|
| Cvijic Christine Mikail | SELL | -4,200 | $36.13 | 07/07/2026 | 07/07/2026 |
| Cvijic Christine Mikail | SELL | -600 | $36.02 | 07/06/2026 | 07/07/2026 |
| Cvijic Christine Mikail | SELL | -1,530 | $35.23 | 07/02/2026 | 07/02/2026 |
| Cvijic Christine Mikail | SELL | -739 | $34.06 | 07/01/2026 | 07/02/2026 |
| Woods Keith | BUY | +12,050 | $20.40 | 06/12/2025 | 06/16/2026 |
| Woods Keith | BUY | +7,700 | $42.59 | 06/14/2024 | 06/16/2026 |
| Woods Keith | BUY | +15,400 | $32.30 | 01/16/2024 | 06/16/2026 |
| Woods Keith | OTHER | 0 | Not reported | 12/18/2023 | 06/16/2026 |
| Cvijic Christine Mikail | SELL | -4,800 | $32.44 | 05/06/2026 | 05/08/2026 |
| Shafer Christina | BUY | +120,000 | $28.94 | 05/05/2026 | 05/07/2026 |
| Shafer Christina | OTHER | 0 | Not reported | 04/20/2026 | 04/20/2026 |
| Jordan Julie | SELL | -828 | $21.89 | 03/26/2026 | 03/30/2026 |
| McMinn Rachel | SELL | -3,352 | $22.07 | 03/26/2026 | 03/30/2026 |
| Cvijic Christine Mikail | SELL | -2,558 | $21.62 | 03/26/2026 | 03/30/2026 |
| Cvijic Christine Mikail | SELL | -263 | $22.02 | 03/13/2026 | 03/17/2026 |
| Cobb Stuart | SELL | -148 | $22.08 | 03/13/2026 | 03/17/2026 |
| Cvijic Christine Mikail | SELL | -4,800 | $25.11 | 02/27/2026 | 03/03/2026 |
| Woods Keith | BUY | +12,050 | $17.64 | 02/20/2026 | 02/24/2026 |
| Freedland Cory S. | BUY | +12,050 | $17.64 | 02/20/2026 | 02/24/2026 |
| Noonberg Sarah B. | BUY | +12,050 | $17.64 | 02/20/2026 | 02/24/2026 |